Author

Jacques J. Bergman

What I regretted most in the treatment of Barrett's early cancer
What I regretted most in the treatment of Barrett's early cancer

Jacques J. Bergman

Entering a New Era of Endoscopy (Olympus)
Entering a New Era of Endoscopy (Olympus)

Jacques J. Bergman  et al.

Mistakes in... endoscopic treatment of Barrett oesophagus neoplasia
Mistakes in... endoscopic treatment of Barrett oesophagus neoplasia

Jacques J. Bergman  et al.

INTENSIVE ENDOSCOPIC THERAPY FOR UNTREATED CERVICAL STRICTURES AFTER ESOPHAGECTOMY: A PILOT STUDY
INTENSIVE ENDOSCOPIC THERAPY FOR UNTREATED CERVICAL STRICTURES AFTER ESOPHAGECTOMY: A PILOT STUDY

Jacques J. Bergman  et al.

SINGLE WAVELENGTH ENDOSCOPY FOR THE ASSESSMENT OF BARRETT’S OESOPHAGUS: EXPERT AND NON-EXPERT OPTICAL DIAGNOSIS USING DIFFERENT IMAGING TECHNIQUES
SINGLE WAVELENGTH ENDOSCOPY FOR THE ASSESSMENT OF BARRETT’S OESOPHAGUS: EXPERT AND NON-EXPERT OPTICAL DIAGNOSIS USING DIFFERENT IMAGING TECHNIQUES

Jacques J. Bergman  et al.

FIRST IN-HUMAN STUDY ON THE SAFETY, TOLERABILITY AND EFFICACY OF THE AQUAMEDICAL FOCAL RF-VAPOR ABLATION (RFVA) SYSTEM, FOR THE ERADICATION OF BARRETT'S ESOPHAGUS (BE): THE STEAM-BE DOSIMETRY STUDY
FIRST IN-HUMAN STUDY ON THE SAFETY, TOLERABILITY AND EFFICACY OF THE AQUAMEDICAL FOCAL RF-VAPOR ABLATION (RFVA) SYSTEM, FOR THE ERADICATION OF BARRETT'S ESOPHAGUS (BE): THE STEAM-BE DOSIMETRY STUDY

Jacques J. Bergman  et al.

ENDOSCOPIC VACUUM THERAPY FOR PATIENTS WITH ANASTOMOTIC LEAKAGE AFTER ESOPHAGO-GASTRIC SURGERY
ENDOSCOPIC VACUUM THERAPY FOR PATIENTS WITH ANASTOMOTIC LEAKAGE AFTER ESOPHAGO-GASTRIC SURGERY

Jacques J. Bergman  et al.

FOCAL C2 CRYOBALLOON (TM) ABLATION WITH 8SEC DOSE HAS SIMILAR EFFICACY AS 10SEC FOR TREATMENT OF BARRETT’S ESOPHAGUS RELATED NEOPLASIA
FOCAL C2 CRYOBALLOON (TM) ABLATION WITH 8SEC DOSE HAS SIMILAR EFFICACY AS 10SEC FOR TREATMENT OF BARRETT’S ESOPHAGUS RELATED NEOPLASIA

Jacques J. Bergman  et al.

CHANGES IN INCRETINS, BILE ACIDS AND THE MICROBIOME AFTER DUODENAL MUCOSAL RESURFACING IN PATIENTS WITH TYPE 2 DIABETES
CHANGES IN INCRETINS, BILE ACIDS AND THE MICROBIOME AFTER DUODENAL MUCOSAL RESURFACING IN PATIENTS WITH TYPE 2 DIABETES

Jacques J. Bergman  et al.

A COMPUTER-AIDED DIAGNOSIS (CADX) SYSTEM FOR CHARACTERIZATION OF BARRETT’S NEOPLASIA
A COMPUTER-AIDED DIAGNOSIS (CADX) SYSTEM FOR CHARACTERIZATION OF BARRETT’S NEOPLASIA

Jacques J. Bergman  et al.

A COMPUTER AIDED DETECTION SYSTEM FOR BARRETT'S NEOPLASIA IMPROVES NEOPLASIA DETECTION
A COMPUTER AIDED DETECTION SYSTEM FOR BARRETT'S NEOPLASIA IMPROVES NEOPLASIA DETECTION

Jacques J. Bergman  et al.

LINKED COLOR IMAGING IMPROVES IDENTIFICATION OF EARLY GASTRIC CANCER FOR BOTH EXPERT AND NON-EXPERT ENDOSCOPISTS
LINKED COLOR IMAGING IMPROVES IDENTIFICATION OF EARLY GASTRIC CANCER FOR BOTH EXPERT AND NON-EXPERT ENDOSCOPISTS

Jacques J. Bergman  et al.

Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement

Jacques J. Bergman  et al.

INTEGRATED FRAME INFORMATIVENESS ASSESSMENT ALGORITHM FOR BARRETT’S NEOPLASIA
INTEGRATED FRAME INFORMATIVENESS ASSESSMENT ALGORITHM FOR BARRETT’S NEOPLASIA

Jacques J. Bergman  et al.

ADDITION OF LINKED COLOR IMAGING TO WHITE LIGHT ENDOSCOPY IMPROVES DELINEATION PERFORMANCE OF EARLY GASTRIC CANCER LESIONS BY NON-EXPERT ENDOSCOPISTS
ADDITION OF LINKED COLOR IMAGING TO WHITE LIGHT ENDOSCOPY IMPROVES DELINEATION PERFORMANCE OF EARLY GASTRIC CANCER LESIONS BY NON-EXPERT ENDOSCOPISTS

Jacques J. Bergman  et al.

DUODENAL MUCOSAL RESURFACING COMBINED WITH GLP-1 RECEPTOR AGONISM MAY ELIMINATE INSULIN TREATMENT IN TYPE 2 DIABETES WHILE IMPROVING GLYCAEMIC CONTROL AND OVERALL METABOLIC HEALTH
DUODENAL MUCOSAL RESURFACING COMBINED WITH GLP-1 RECEPTOR AGONISM MAY ELIMINATE INSULIN TREATMENT IN TYPE 2 DIABETES WHILE IMPROVING GLYCAEMIC CONTROL AND OVERALL METABOLIC HEALTH

Jacques J. Bergman  et al.

INDEPENDENT VALIDATION OF TISSUECYPHER TO PREDICT PROGRESSION IN COMMUNITY-BASED BARRETT'S ESOPHAGUS WITH LOW-GRADE DYSPLASIA: ANALYSIS IN A COMPLETED PROSPECTIVE STUDY
INDEPENDENT VALIDATION OF TISSUECYPHER TO PREDICT PROGRESSION IN COMMUNITY-BASED BARRETT'S ESOPHAGUS WITH LOW-GRADE DYSPLASIA: ANALYSIS IN A COMPLETED PROSPECTIVE STUDY

Jacques J. Bergman  et al.

ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED HIGH-RISK MUCOSAL ADENOCARCINOMA AND LOW- AND HIGH-RISK SUBMUCOSAL ADENOCARCINOMA ARISING IN BARRETT'S ESOPHAGUS, RESULTS OF 120 PATIENTS FROM THE DUTCH BARRETT EXPERT CENTER COHORT
ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED HIGH-RISK MUCOSAL ADENOCARCINOMA AND LOW- AND HIGH-RISK SUBMUCOSAL ADENOCARCINOMA ARISING IN BARRETT'S ESOPHAGUS, RESULTS OF 120 PATIENTS FROM THE DUTCH BARRETT EXPERT CENTER COHORT

Jacques J. Bergman  et al.

RANDOM BIOPSIES FROM THE GASTRO-ESOPHAGEAL JUNCTION AFTER COMPLETE ERADICATION OF BARRETT’S ESOPHAGUS: UTILE OR FUTILE?
RANDOM BIOPSIES FROM THE GASTRO-ESOPHAGEAL JUNCTION AFTER COMPLETE ERADICATION OF BARRETT’S ESOPHAGUS: UTILE OR FUTILE?

Jacques J. Bergman  et al.

THE NATURAL COURSE OF UNTREATED NEOPLASIA IN BARRETT’S ESOPHAGUS - A CASE-SERIES
THE NATURAL COURSE OF UNTREATED NEOPLASIA IN BARRETT’S ESOPHAGUS - A CASE-SERIES

Jacques J. Bergman  et al.

Item 1 - 20 / 24
1
2